Real‐world effectiveness and tolerability of cenobamate in drug‐resistant epilepsy: A retrospective analysis of the patients included into the Early Access Programs (EAP) in Germany, France, and United Kingdom

Abstract Objective Investigate real‐world outcomes in drug‐resistant epilepsy (DRE) patients treated with cenobamate as adjunctive treatment to other antiseizure medications (ASMs) within the Early Access Programs (EAP) in Germany, France, and the United Kingdom. Methods DRE adults with uncontrolled...

Повний опис

Бібліографічні деталі

Автори:	Sylvain Rheims, Bernhard J. Steinhoff, Edouard Hirsch, Felix Rosenow, Arnaud Biraben, Rhys Thomas, Alessandro Lovera, Paola Lipone, Alessandro Comandini, Caroline Benoist, Elena Alvarez Baron, John Paul Leach, Karthinathan Thangavelu, Agnese Cattaneo
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Wiley 2025-06-01
Серія:	Epilepsia Open
Предмети:	antiseizure medication cenobamate responder rate seizure freedom
Онлайн доступ:	https://doi.org/10.1002/epi4.70021
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!